دسترسی نامحدود
برای کاربرانی که ثبت نام کرده اند
برای ارتباط با ما می توانید از طریق شماره موبایل زیر از طریق تماس و پیامک با ما در ارتباط باشید
در صورت عدم پاسخ گویی از طریق پیامک با پشتیبان در ارتباط باشید
برای کاربرانی که ثبت نام کرده اند
درصورت عدم همخوانی توضیحات با کتاب
از ساعت 7 صبح تا 10 شب
ویرایش: 4 نویسندگان: Anthony R. Fooks (editor), Alan C. Jackson (editor) سری: ISBN (شابک) : 0128187050, 9780128187050 ناشر: Academic Press سال نشر: 2020 تعداد صفحات: 717 زبان: English فرمت فایل : PDF (درصورت درخواست کاربر به PDF، EPUB یا AZW3 تبدیل می شود) حجم فایل: 12 مگابایت
در صورت تبدیل فایل کتاب Rabies: Scientific Basis of the Disease and Its Management به فرمت های PDF، EPUB، AZW3، MOBI و یا DJVU می توانید به پشتیبان اطلاع دهید تا فایل مورد نظر را تبدیل نمایند.
توجه داشته باشید کتاب هاری: مبانی علمی بیماری و مدیریت آن نسخه زبان اصلی می باشد و کتاب ترجمه شده به فارسی نمی باشد. وبسایت اینترنشنال لایبرری ارائه دهنده کتاب های زبان اصلی می باشد و هیچ گونه کتاب ترجمه شده یا نوشته شده به فارسی را ارائه نمی دهد.
هاری: اساس بیماری و مدیریت آن، نسخه چهارم مرجع معتبری در مورد وضعیت فعلی هاری، از جمله جنبههای ویروسشناسی، بالینی، بهداشت عمومی و توصیههای مدیریتی است. هاری یکی از مهمترین مشکلات بهداشت عمومی جهانی در سراسر جهان است. اگرچه پیشرفتهای مهم بسیاری در قرن گذشته برای مبارزه با این بیماری صورت گرفته است، اما هاری به یک عفونت دوباره ظهور یافته در کشورهای دارای منابع محدود تبدیل شده است. نسخه چهارم این مرجع کلاسیک را با پوشش جامع ویروس شناسی مولکولی، پاتوژنز، ایمونولوژی، واکسن ها، جنبه های بهداشت عمومی و اپیدمیولوژی هاری به روز می کند و به طور کامل تجدید نظر شده است، با فصل های جدیدی که تحولات تاریخی در استراتژی های مداخله هاری، تکامل را پوشش می دهد. ویروس هاری، مدل سازی کنترل هاری و استراتژی حذف هاری. هاری، نسخه چهارم، پزشکان، دامپزشکان، مشاوران بهداشت عمومی، اپیدمیولوژیست ها و دانشمندان تحقیقاتی را با یک منبع واحد برای اطلاعات معتبر و به روز در مورد تشخیص، درمان، کنترل و پیشگیری از این ویروس عفونی کشنده.
Rabies: Basis of the Disease and Its Management, Fourth Edition is an authoritative reference on the current status of rabies, including the virological, clinical, and public health aspects and management recommendations. Rabies remains one of the most important global public health problems worldwide. Although many important developments have been made over the past century to combat this disease, rabies has become a re-emergent infection in the resource-constrained countries. The Fourth Edition updates this classic reference with comprehensive coverage of the molecular virology, pathogenesis, immunology, vaccines, public health aspects, and epidemiology of rabies and is completely revised, with new chapters that will cover historical developments in rabies intervention strategies, the evolution of rabies virus, modeling rabies control, and on the strategy for rabies elimination. Rabies, Fourth Edition, provides physicians, veterinarians, public health advisors, epidemiologists, and research scientists with a single source for authoritative and up-to-date information on the diagnosis, treatment, control, and prevention of this fatal infectious virus.
Cover RABIES Scientific Basis of the Disease and Its Management Copyright Contributors Foreword Preface 1 A history of rabies-The foundation for global canine rabies elimination Introduction Asia A seat of canine domestication? Dogs, deaths, and divinities The disease and perceived remedies Postcolonial occurrence Semple's antirabic vaccine Additional progress throughout the 20th century Current status Europe Early incursions Recognition and control measures Wildlife rabies appreciation Oral vaccination applications Reintroductions Europe as rabies-free?! Africa Indigenous roots or regional translocations? Wildlife involvement Molecular insights Control measures Other lyssaviruses Toward 2030? South America, Central America, and the Caribbean Colonization impacts Centuries absent-canine rabies? The ``spillover´´ phenomenon From initial evidence to the successful vaccinations Regional efforts: Large-scale vaccination and laboratory-based surveillance Setbacks The emerging challenges of bat rabies Future perspectives North America Australia RABV ABLV References 2 Rabies virus Introduction Lyssaviruses Rabies virus architecture Virus structure and composition Morphology and core structure of standard and defective virus particles Viral proteins Nucleoprotein (N) Phosphoprotein (P) Virion-associated RNA polymerase or large protein (L) Matrix protein (M) Glycoprotein (G) Viral lipids and carbohydrate Genome and RNP structures Genome primary structure Lyssavirus genes Transcription of genes Replication of RABV N-vRNA genomes Regulation of transcription and replication Structural aspects of RABV RNA synthesis Life cycle of rabies virus infection Early-phase events: Role of the RABV receptor, endocytosis, and G-mediated fusion Middle-phase events: Transcription, replication, and nascent protein synthesis Viral RNP release, initiation of genome RNA transcription, replication, and protein synthesis Late phase: Assembly and budding of progeny virus Cell-to-cell spread (transport) of progeny virus References Further reading 3 Evolution of rabies virus Introduction Microevolutionary dynamics of rabies in stable host virus associations Macroevolutionary dynamics of rabies Reconciling strains of evidence for the role of adaptive evolution in cross-species transmission Applications of evolutionary data for rabies prevention and control-genetics as a tag on transmission Conclusions References 4 Epidemiology Introduction Global rabies epidemiology Asia Africa Middle East Europe North America Caribbean islands South America Oceania RABV transmission Typical routes of transmission Atypical routes of transmission Incubation period Viral shedding Enzootic cycles Cross-species transmission Host shift events Translocation events Surveillance general Principles of rabies surveillance Global limitations in surveillance capacity Rationale for implementing rabies surveillance systems Critical components of functional surveillance systems Laboratory diagnostic methods for effective surveillance system Future of integrated surveillance approaches Human rabies: Public health measures Animal rabies: Epidemiology and control Bats Terrestrial carnivores Domestic dogs Wildlife species of special concern References 5 Molecular epidemiology Introduction Key aspects of Lyssavirus biology Methods of viral typing Genetic characterization of lyssaviruses Application of high-throughput sequencing (HTS) methods Principles of phylogenetic analysis Lyssavirus taxonomy Lyssavirus species Molecular epidemiology of rabies-related lyssaviruses Australian bat lyssavirus European bat lyssaviruses Asian bat lyssaviruses Lyssaviruses of Africa Duvenhage lyssavirus Lagos bat lyssavirus Shimoni bat lyssavirus Mokola lyssavirus Ikoma lyssavirus Future issues Molecular epidemiology of rabies lyssaviruses Cosmopolitan lineage Africa 2 Africa 3 Arctic/Arctic-like Indian subcontinent Asian American indigenous Emerging trends The importance of viral typing Understanding the factors impacting viral spread Role of the host What controls host shift events? Impact of climate change Concluding remarks Acknowledgments References 6 Rabies in terrestrial animals Introduction General pathogenesis Incubation period Clinical signs Lyssavirus infections in reservoir species Basic concepts of reservoir host ecology for terrestrial rabies Reservoir hosts for terrestrial rabies Canidae Domestic dogs Foxes Red foxes Arctic foxes Other foxes Raccoon dog Jackals and coyotes Raccoons Skunks Mongooses Ferret badgers Marmosets Spillover (dead-end) hosts for terrestrial rabies Cats Cattle Kudu Wolves, African wild dogs, and other carnivores Rodents, opossums, and marsupials Acknowledgments References 7 Bat rabies Introduction Bat rabies in the New World Vampire bat rabies: Historical perspectives Rabies and insectivorous bats in the Americas Bat rabies in the Old World Eurasian lyssaviruses European bat-1 lyssavirus European bat-2 lyssavirus Aravan bat lyssavirus Khujand bat lyssavirus West Caucasian bat lyssavirus Irkut bat lyssavirus Bokeloh bat lyssavirus Lleida bat lyssavirus Unclassified viruses African lyssaviruses Lagos bat virus Duvenhage virus Shimoni bat lyssavirus African lyssaviruses not associated with bats Asian and Australian lyssaviruses Australian bat lyssavirus Gannoruwa bat lyssavirus Unclassified Australasian viruses Experimental studies with lyssaviruses in bats New World lyssavirus studies in bats Insectivorous bat RABV Hematophagous bat RABV Old World lyssavirus studies in bats EBLV-1 EBLV-2 ABLV ARAV, KHUV, IRKV, WCBV LBV Important knowledge gaps and challenges to lyssavirus research Aerosol transmission The role of torpor in potential maintenance of bat lyssavirus infections Inoculation route and dose Lyssavirus excretion The caveats of using wild caught bats in laboratory studies Complexities of bat surveillance initiatives Abortive infection and carrier state in bats Future experimental approaches Future prospects for controlling lyssaviruses in bats Conclusions Acknowledgments References 8 Human disease Introduction Exposures, incubation period, and prodromal symptoms Clinical forms of disease Encephalitic rabies Paralytic rabies Investigations Imaging studies Laboratory studies Detection of RABV RNA Brain tissues Differential diagnosis Rabies due to other Lyssavirus species Duvenhage virus Mokola virus European bat lyssavirus 1 European bat lyssavirus 2 Australian bat lyssavirus Irkut virus Conclusions References 9 Pathogenesis Introduction Virus entry into the nervous system Earliest events Superficial and nonbite exposures RABV receptors Nicotinic acetylcholine receptor Neural cell adhesion molecule (NCAM) receptor Low-affinity p75 neurotrophin receptor Metabotropic glutamate receptor subtype 2 Spread to the CNS Spread within the CNS Spread from the CNS Animal models of RABV neurovirulence Structural damage caused by RABV infection in the CNS Innate immune responses Apoptosis Degeneration of neuronal processes Blood-brain-barrier (BBB) Brain dysfunction in rabies Neuropeptide synthesis during rabies Defective neurotransmission Acetylcholine Serotonin γ-Amino-n-butyric acid Electrophysiological alterations Ion channels Nitric oxide Excitotoxicity Oxidative stress Mitochondrial dysfunction Bases for behavioral changes Recovery from rabies and chronic RABV infection Conclusions References 10 Pathology Introduction Macroscopic findings Pathology in the central nervous system Overview Inflammation Cell injury and cell death Negri and lyssa bodies Degeneration of neuronal processes Distribution of rabies virus antigen Pathology in the peripheral nervous system Changes in sensory and autonomic ganglia Changes in spinal nerve roots and peripheral nerves Pathology involving the inoculation site, eye, and extraneural organs Changes at inoculation site Ocular pathology Changes in extraneural organs Summary and conclusions References 11 Immunology Introduction RABV innate immune response RABV triggering of host innate immune response and virus evasive mechanisms Innate immune response in the periphery Innate immune response in the NS RABV evasion of the IFN response in infected neurons RABV limits the inflammatory response in the NS RABV adaptive immune response RABV specific immune response in the periphery RABV provokes the killing of migratory T cells Entry of lymphocytes in the RABV-infected NS Destruction of T cells in the RABV-infected NS RABV infection triggers a CNS-mediated immune unresponsiveness Paradoxical role of IFN in RABV virulence Conclusions References 12 Laboratory diagnosis of rabies Laboratory-based rabies diagnostic testing Indications for rabies testing Biosafety and shipment of diagnostic specimens Quality assurance Optimal sampling for rabies diagnosis Laboratory reporting practices History of rabies diagnostic tests Detection of viral antigen The direct fluorescent antibody test Fluorescent conjugate selection, preparation, and evaluation Immunofluorescence test protocol Direct rapid immunohistochemical test Lateral flow assays Immunohistochemistry on formalin-fixed paraffin embedded tissues Enzyme-linked immunosorbent assay Molecular methods of viral RNA detection Advantages and disadvantages of molecular methods RNA extraction Reverse transcription-polymerase chain reaction methods Primer design Reverse transcription Polymerase chain reaction PCR product detection Real-time RT-PCRs for lyssavirus detection The 5 nuclease assay Assays using intercalating dyes Choice of assay Required controls Mock extraction control Positive and negative PCR controls Control for template integrity Application of molecular methods to fixed tissues Application of RT-PCR in research Other molecular methods for rabies virus detection Detection of live virus Antemortem diagnosis of rabies Conclusions Acknowledgments References 13 Measures of rabies immunity Introduction Rabies serology methods Serum neutralization assays ELISA, IFA, and immunochromatographic assays Assay selection Assuring quality results Defining ``adequate´´ or ``minimum´´ response to rabies vaccination Regulatory compliance Conclusions References 14 Human and animal vaccines Introduction History of rabies vaccines Pre-exposure prophylaxis Post-exposure prophylaxis Rabies virus strains for vaccine production Production of rabies vaccines Cell substrates for rabies virus propagation Primary cells Diploid cells Continuous cell lines Production systems Viral inactivation Downstream processing RABV purification Formulation Potency testing Safety issues and mitigation strategies Oral rabies vaccination Wildlife Domestic animals Monitoring oral rabies vaccination Future directions References 15 Next generation of rabies vaccines Introduction Current rabies vaccine regimens Incidence and risk for rabies and vaccine failures Correlates of protection Novel vaccines to rabies Live attenuated rabies virus vaccines Inactivated genetically modified rabies vaccine Inactivated adjuvanted traditional rabies vaccines Peptide vaccines Protein vaccines Genetic vaccines DNA vaccines RNA vaccines Viral vector vaccines Recombinant poxviruses Recombinant adenoviruses The ``ideal´´ rabies vaccine Summary References 16 Public health management of humans at risk Introduction Obstacles to preventing rabies in humans Exposure Vaccination protocols to prevent rabies Preexposure vaccination Postexposure vaccination Before vaccination begins Rabies immune globulin PEP vaccination regimens Previously vaccinated individuals and booster vaccinations Special populations Pregnancy Immunocompromised patients Travelers Adverse reactions to cell culture vaccines Interchangeability and coadministration of vaccines Educational initiatives Reducing vaccination regimens Conclusions and future References Further reading 17 Therapy of human rabies Human cases with recovery from rabies Milwaukee protocol Future prospects for the aggressive management of rabies in humans Critical care unit Combination therapy Antiviral therapy Immunotherapy Neuroprotective therapy Specific therapies to avoid Importance of palliation in the management of rabies References 18 Dog rabies and its control Introduction Historical perspectives and the current situation The burden of domestic dog-mediated rabies The influence of epidemiological and socioeconomic frameworks on dog rabies control Key epidemiological parameters Epidemiological factors influencing the effectiveness of control efforts Beyond ``effectiveness´´: Exploring social dimensions of rabies control Dog population management Culling Sterilization programs Practical aspects of dog rabies control Planning phase Implementation of mass dog vaccination campaigns Measuring the impact of mass dog vaccination campaigns Vaccination coverage Surveillance Maintaining rabies-free status Economics of dog vaccination for rabies control Extended benefits of dog rabies control Conclusions References 19 Rabies control in wild carnivores Introduction Historical aspects, milestones, and epizootiology Europe North America Asia Africa Central America, South America, and the Caribbean Conceptual foundations and principles Structure and operation of control programs Communication and collaboration Enhanced surveillance Management actions Population reduction Trap-vaccinate-release Oral rabies vaccination Contingency actions Translocation Program monitoring and evaluation Bait and vaccine principles, research and developments Vaccines Baits Conclusions Acknowledgments References 20 Modeling canine rabies virus transmission dynamics Introduction History of modeling rabies virus transmission dynamics The modeling backbone for canine rabies How to model rabies virus transmission? Existing modeling studies Insights and limitations The gap between models and data Bite data Laboratory-confirmed case data Sequence data Dog population and vaccination data Conclusions Data and code availability References 21 Strategies for the elimination of dog-mediated human rabies by 2030 Introduction Sustainability requires government ownership and commitment Tools to support sustainable rabies elimination programs Global disease elimination/eradication strategies Disease prioritization Organization and planning for rabies elimination Financing International guidelines/recommendations Declaration of freedom Networks Monitoring and surveillance Monitoring of vaccination events Conclusions References 22 Future developments and challenges Introduction Pathogenesis Therapy of human rabies Epidemiology Prevention of human rabies Control of animal rabies Health impact and economic burden of canine rabies Conclusions References Index A B C D E F G H I J K L M N O P Q R S T V W Back Cover